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Abstract: Plasmodium vivax Cysteine-Rich Protective Antigen (CyRPA) is a merozoite protein partici-
pating in the parasite invasion of human reticulocytes. During natural P. vivax infection, antibody
responses against PvCyRPA have been detected. In children, low anti-CyRPA antibody titers corre-
lated with clinical protection, which suggests this protein as a potential vaccine candidate. This work
analyzed the genetic and amino acid diversity of pvcyrpa in Mexican and global parasites. Consensus
coding sequences of pvcyrpa were obtained from seven isolates. Other sequences were extracted
from a repository. Maximum likelihood phylogenetic trees, genetic diversity parameters, linkage
disequilibrium (LD), and neutrality tests were analyzed, and the potential amino acid polymorphism
participation in B-cell epitopes was investigated. In 22 sequences from Southern Mexico, two synony-
mous and 21 nonsynonymous mutations defined nine private haplotypes. These parasites had the
highest LD-R2 index and the lowest nucleotide diversity compared to isolates from South America
or Asia. The nucleotide diversity and Tajima’s D values varied across the coding gene. The exon-1
sequence had greater diversity and Rm values than those of exon-2. Exon-1 had significant positive
values for Tajima’s D, β-α values, and for the Z (HA: dN > dS) and MK tests. These patterns were
similar for parasites of different origin. The polymorphic amino acid residues at PvCyRPA resembled
the conformational B-cell peptides reported in PfCyRPA. Diversity at pvcyrpa exon-1 is caused by
mutation and recombination. This seems to be maintained by balancing selection, likely due to
selective immune pressure, all of which merit further study.
Keywords: Plasmodium vivax; pvcyrpa; Southern Mexico; Cysteine-Rich Protective Antigen (CyRPA);
merozoite protein; genetic diversity; Tajima’s D; MK test; phylogenetic tree; balancing selection
1. Introduction
Malaria is a disease that affects millions of people worldwide. In the Americas, P. vivax
is widely distributed and the number of cases and severity of the disease has increased in
recent years [1]. Malaria vaccines using merozoite proteins aim to reduce parasitemia and,
consequently, the disease’s severity [2]. This approach eventually reduces transmission
at the regional level, which is necessary to achieve malaria elimination [3]. Furthermore,
merozoite proteins that induce antibody responses are useful markers for serological
surveillance [4,5].
For blood infection to occur, Plasmodium merozoite invasion requires multiple and
sequential interactions between the protein ligands and the erythrocyte surface receptors.
In Plasmodium falciparum, the cysteine-rich protective antigen (CyRPA) has been studied
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more than in other Plasmodium species. PfCyRPA forms a complex with other proteins and
is essential in the sequential molecular events leading to the merozoite invasion of human
erythrocytes [6]. PfCyRPA is capable of binding to the reticulocyte-binding homolog 5
protein (PfRH5) and the RH5-interacting protein (PfRipr). The PfRH5/PfRIPR/CyRPA
complex is highly immunogenic, making these proteins promising vaccine components
against malarial blood stages [7]. The PfCyRPA protein sequence has been highly conserved
among global parasite strains; in exposed individuals from Ghana, anti-PfCyRPA antibod-
ies were not detected [7]. In P. falciparum, anti-CyRPA-specific antibodies substantially
inhibited erythrocyte invasion by merozoites in in vitro culture and in an in vivo NOD-scid
IL2Rγ (null) mouse model grafted with human erythrocytes [8]. Recent studies have shown
the high immunogenicity of PfCyRPA delivered in virosomes to immunized mice and
rabbits. In addition, the IgG from immunized rabbits reduced parasite development to 77%
in a P. falciparum infection mouse model [9].
In the P. knowlesi and P. vivax genomes, the RH5 coding gene is not present. In
P. knowlesi, the RIPR and CyRPA proteins do not seem to form a complex with each other;
rather RIPR forms a novel trimeric protein complex with other molecules, whereas CyRPA,
as a single protein, is essential for merozoite invasion [10]. Knuepfer et al. [10] showed
that erythrocyte receptor basigin (BSG) might not be essential for erythrocyte invasion in
P. knowlesi, as it is in P. falciparum [7].
In P. vivax, the cyrpa gene consists of two exons and one intron located on chromosome
five, encoding for a microneme protein. Anti-BSG receptor antibodies caused different
growth inhibition rates in field isolates and suggested that BSG might be an alternative
receptor on the reticulocyte for merozoite invasion [10]. Unlike in P. falciparum, P. vivax
CyRPA seems to be exposed to the immune system. In young children, CyRPA induced
high IgG antibody levels against P. vivax during the infection, and low antibody titers were
strongly associated with protection from the clinical disease [11].
To understand the potential of PvCyRPA in vaccine development and/or as a sero-
logical marker, the nucleotide and amino acid diversity, and the natural selection acting
on this molecule were studied in symptomatic patients in Southern Mexico and compared
to parasites from other geographical origins. The polymorphism of the peptide regions
that potentially participate as B-cell epitopes was explored. Homologous sequences of
different origins were retrieved from a repository and included in the analysis. Our results
show that pvcyrpa had lower nucleotide diversity in parasites from Southern Mexico than
in parasites from South America or Asia. This diversity has been shaped by mutation and
recombination, and it has probably been maintained by balancing selection. The pattern
of nucleotide diversity across the coding gene was consistent in parasites of different
origin, with exon-1 showing a greater number of nonsynonymous mutations than exon-2.
The neutrality and selection tests suggest that pvcyrpa exon-1 is probably under positive
balancing selection pressure; accordingly, the amino acid variation was detected in peptide
regions predicted as being B-cell epitopes. These findings suggest that recombination and
immune selective pressure played a role in shaping PvCyRPA diversity.
2. Materials and Methods
The Ethics Committee of the Mexican National Institute of Public Health project
(CI1042) approved the study, and informed consent was obtained from the patients. All the
samples analyzed were obtained from adults (over 18 years of age).
2.1. Samples and Origin
Ten blood samples infected with P. vivax were selected for this study, obtained between
2000 and 2015 from the Pacific side of Southern Chiapas, Mexico (Southern Mexico). In
this region, after implementing intensive and simultaneous measures based on vector
control and patient management, P. falciparum was eliminated late in the 1990s while
P. vivax transmission remained. From 2000 onwards, the number of malaria cases decreased
gradually over time. Mexico entered the pre-elimination phase in 2007 [12]. Most patients
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from the region experienced an uncomplicated disease [13]. In symptomatic patients
showing no severe symptoms and seeking a malaria diagnosis, P. vivax was diagnosed via
microscopy using a thick Giemsa-stained smear. Capillary blood samples from finger pricks
were used to impregnate Whatman #2 filter paper. Afterwards, the patients were treated in
accordance with the Mexican guidelines for malaria treatment, and the administration of
treatments based on chloroquine and primaquine was supervised by the malaria control
program officials [14]. Dried P. vivax blood samples were kept at 4 ◦C in the dark prior
to use.
2.2. DNA Extraction, PCR Amplification and Sequencing
Genomic DNA from whole infected blood samples was extracted using the GeneJET
Whole Blood Genomic DNA Purification Mini Kit (Thermo Fisher Scientific, Asheville,
NC 28803, USA), as indicated by the manufacturer. P. vivax single infection was verified
using species-specific oligonucleotides (Table 1), and the conditions for the nested PCR
using the UNR, PLF and VIR primers were as described by Rubio et al. [15]. To obtain
and sequence the pvcyrpa coding gene, nine primers were designed (Table 1). The IDT
Company (Integrated DNA Technologies, Inc., Coralville, IA 52241, USA) synthesized the
oligonucleotides.
Table 1. PCR primers used for the diagnosis and amplification of the pvcyrpa gene.
Primer Sequence (5′–3′) Specificity Reference
Reverse primer UNR GACGGTATCTGATCGTCTTC Universal [15]
Forward primer PLF AGTGTGTATCCAATCGAGTTTC Plasmodium [15]
Reverse primer VIR AGGACTTCCAAGCCGAAGC P. vivax [15]
CYRPA_R1 AGTTGGGATGTGCTACTGGAG P. vivax This article
CYRPA_F1 TAAGTCTGCTTTCCTCTCTTGGG P. vivax This article
CYRPA_R2 AGACTGGAAAGACGCAACGG P. vivax This article
CYRPA_F2 TTGGAGGGACTTGTCCGGTT P. vivax This article
CYRPA_R3 TGCTCTGTGTAGTAGAGG P. vivax This article
CYRPA_F3 TTTTTCTCCCCTTGGGAGGCTAC P. vivax This article
CYRPA_R4 GTGGAAAGAAGTGTGTGGAGGT P. vivax This article
CYRPA_F4 TATGGGACTTTTGATGGTTG P. vivax This article
CYRPA_R5 AACTGACTGGTATGAGTCC P. vivax This article
CYRPA R1, F1, R2, and F2 primers were designed from the sequencing of several
P. vivax strains retrieved from available databases, while ClustalW in Bioedit v7.0.5.3 [16,17]
was used for DNA alignment. The internal primers CYRPA_R3, F3, R4, F4, and R5 were
designed to complete the DNA coding sequence. The first amplification was performed
with the SensiFAST™ PCR Kit (Bioline, Cincinnati, OH 45244, USA) in a final volume of
20 µL, using 200 ng of the whole genomic in a reaction containing the buffer (supplied
by the manufacturer) and 5 ng of each of the primers. The PCR conditions consisted of a
denaturation step in a MyGo Pro thermal cycler (Biocompare, Inc., Kansas City, MO 66103,
USA) at 94 ◦C for 5 min, followed by 40 cycles, each at 94 ◦C for 45 s, 61 ◦C for 45 s, and
72 ◦C for 60 s, with a final extension at 72 ◦C for 10 min. Then, a nested PCR was performed
using 0.1 µL of the previous PCR product with a denaturation step of 94 ◦C for 5 min,
followed by 40 cycles at 94 ◦C for 30 s, 60 ◦C for 30 s, and 72 ◦C for 30 s, and the final
extension at 72 ◦C for 10 min. The expected molecular size of the amplified products was
verified using 1% agarose gels and visualized in a transilluminator.
The PCR products were purified using the mi-PCR Purification Kit (Metabion, 82152
Planegg, Germany) according to the manufacturer’s instructions. Afterwards, 5–50 ng of
DNA were used per sequencing reaction employing the Sanger method, using forward and
reverse primers in the ABI PRISM® 3500 Genetic Analyzer System (Applied Biosystems,
Carlsbad, CA 92008, USA); this was carried out at the nucleic acid analysis service of the
Central Research Services at the University of Almeria, Spain.
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The quality of the pherograms was revised manually, and using ClustalW in BioEdit,
including Sal I sequence XM_001615090.1 [18] as the reference. No pherograms with
double peaks were detected, which suggests that there was more than one genotype
in the amplified DNA fragments. This coincided with previous work using Pvama1I-II,
which showed a very low proportion of mixed genotype infections from 2000 to 2011
in Southern Mexico [19]. Numerous alignments were run using forward and reverse
sequences to obtain the consensus sequences of the complete pvcyrpa coding genes. The
sequences were deposited in the GenBank database, identified with the accession numbers
MW010262–MW010268.
2.3. Gene Sequences
Seven sequences of the pvcyrpa coding gene were obtained in this study. Other
homologous sequences from the same region (Southern Mexico) and from other geographic
sites, were retrieved from a repository (https://plasmodb.org/plasmo/; n = 82) and
included in the analysis (Table S1). For Southern Mexico, there were 22 coding sequences
in total, comprising seven sequences from this study and 15 from the repository [20]. All
the sequences were from parasites obtained in Southern Mexico (Figure S1). Two other
sequence groups were prepared. The South American group consisted of 45 sequences
(21 and 24 sequences of isolates from Colombia and Peru, respectively), while the Asian
group comprised 19 sequences (9, 4, and 6 sequences of isolates from Thailand, Papua
New Guinea and China, respectively). Three reference sequences were included. Since
pvcyrpa has an intron, only complete sequences (Table S1) were used to estimate the LD
indexes (Table S1).
2.4. Genetic Analysis of the Coding Gene
To search for genetic similarities among haplotypes from Southern Mexico, and from
around the world, maximal likelihood (ML) phylogenetic trees were constructed using
the bootstrap method and 1000 replications in MEGA v6 [21]. Reference sequences from
strains Sal I (XM_001615090.1) and from Belem and P01 (PvP01_0532400) were included.
The genetic diversity parameters and the neutrality tests were estimated using se-
quences from Southern Mexico and from other geographic sites with higher transmission
intensities, namely South America and Asia. The nucleotide diversity distribution across
the pvcyrpa sequence was analyzed using slide window analysis of 100 bp fragments with
25 overlapping nucleotide units in DnaSP [22]. The number of haplotypes (H), the nu-
cleotide (π) and genetic diversity (θ), the haplotype diversity, and the minimal number of
recombination events (Rm) were calculated in DnaSP.
To determine the departure from neutrality of the cyrpa coding gene, different tests
were evaluated. The allele-frequency-based Tajima’s D test was estimated using slide
window analysis per 100 bp and 25 overlapping nucleotides, and for the gene segments
in DnaSP. Fu and Li’s D* and F* tests were estimated—the D* test analyzes differences
between the number of singletons and the total number of mutations while the F* test
computes the differences between the number of singletons and the average number of
nucleotide differences [23]. These tests inform about the selection and demographic forces
acting on a population. Positive values might be suggestive of positive or balancing
selection (if other selection tests are significantly positive). This force maintains alleles at
balanced frequencies. Conversely, negative values suggest purifying selection or recent
population expansion [24].
To detect codons under positive selection across pvcyrpa coding gene, synonymous
and nonsynonymous rates (α, β) were calculated using Fast Unconstrained Bayesian
AppRoximation (FUBAR) in a website software (https://www.datamonkey.org/). This
model uses a probabilistic approach to infer whether the nonsynonymous substitution
rate (β) in a site is faster or slower than the neutral rate, which is set to the synonymous
rate (α) at the same site. Probability, p, <0.05 detected very low false-positive rates (0.5%)
on the neutral and purifying sites [25]. The codon-based Z test can detect if positive
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selection is operating on a gene fragment by comparing the relative numbers of non-
synonymous versus synonymous substitutions and their variances [26]. The alternate
hypothesis (HA: dN > dS) was tested using the Modified Nei-Gojobori method (Jukes-
Cantor) with 1000 bootstrap replications in MEGA v6.; this was done because some genes
that code for antigenic proteins, and that are under strong balancing selection, might
produce positive skews in the McDonald and Kreitman (MK) divergence test, as shown
for malarial blood-stage antigens [27]. To corroborate that recurrent natural selection is
acting on the cyrpa coding sequence, the MK neutrality index [28] was calculated. The
MK test is based on a comparison of synonymous and nonsynonymous variations within
and between species. For this, we used the orthologous sequence of Plasmodium cynomolgi
strain B (XM_004221254) [29], a species closely related to P. vivax [30], and the analysis
was computed in DnaSP. This sequence shows higher (76.8%) protein identity with PvP01
(BlastP, NBCI).
2.5. Linkage Disequilibrium (LD) Analysis and Mutations in the Intron
Sequences containing the complete gene were used to estimate the degree of non-
random association between the haplotypes and at all the informative sites. The D’ and R2
indices of LD were calculated in DnaSP.
2.6. Exploration of Potential Residues Participating in B-cell Epitopes in CYRPA Amino Acid
Sequences of P. vivax From Southern Mexico
Peptides likely to contain B-cell epitopes were sought using the BepiPred method,
which combines the hidden Markov model with one of the best propensity scale methods
for predicting linear B-cell epitopes (https://www.iedb.org/) [31,32]. A threshold of 0.35,
which comprises 75% specificity and 49% sensitivity, was used. The residues above the
threshold are predicted to be part of an epitope. In addition, the accessibility scale was esti-
mated for hexapeptides—if the Sn were above 1.0, this increased the probability that they
were on the protein surface [33]. The P. falciparum cyrpa sequence (http://plasmodb.org;
PF3D7_0423800) was used to make comparisons.
3. Results
3.1. Pvcyrpa Polymorphism at the Coding Gene of Parasites from Southern Mexico
The Sal I sequence and the seven sequences from this study had codons 14-17 (CTC
TTC TCC TTC) at the 5’end. These codons seem to correspond to the signal peptide (4).
There was no information on this segment in the sequences obtained from PlasmoDB;
therefore, it could not be included in the genetic analysis. Twenty-two nucleotide coding
sequences from Southern Mexico (each sequence was obtained from different P. vivax
isolate), had two synonymous and 21 nonsynonymous mutations, and resolved nine
haplotypes. Codon 271, present in the Sal I sequence, was only present in two divergent
haplotypes (h2 and h9) in Southern Mexico (Table 2).
Most mutations present in the pvcyrpa coding gene of the Southern Mexico parasites
were also common in the parasites from South America and Asia (Table S2). Few mutations
were less distributed or private; for example, mutations at codons 139 and 326 were shared
between Southern Mexico and Colombia, present in three and two isolates, respectively.
The mutation at codon 363 was present in one isolate from Southern Mexico, and present
in a single isolate from Thailand. The mutation at codon 82 was exclusive to one isolate
(h7) from Southern Mexico. Of the 57 haplotypes detected globally (n = 89), only two
haplotypes were shared between Peru and Colombia, all the other haplotypes were private
including those resolved for Southern Mexico.
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Table 2. Gene and amino acid variation of the P. vivax cyrpa coding region among Southern Mexican parasites.
Haplotype n Exon-1 Exon-2
Codon Number/Amino acid Residue
69 82 91 93 95 126 127 129 132 139 145 154 159 170 185 220 258 259 260 261 264 271 326 363
Ala Asn Lys Glu Asn Lys Glu Ile Arg Thr Asn Asp Asp Asp Lys Val Leu1 Glu Glu Pro Ser - Asp Thr
Nucleotides
h1 5 + 1 gcg aac Aag gaa Aat aaa gaa atc cgg Acc aac gac gac Gac aaa gtc cta gaa gag ccg agc - gat acg
h2 2 + 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . a.. . . . . . . . . . . . . g.t gaa . . . . . .
h3 3 + 1 .g. . . . .c. a.. c.. g.. .g. .g. ..c . . . gg. .c. ..g a.. g.. a.. . . . . . . . . . . . . . . . - . . . . . .
h4 2 + 0 .g. . . . .c. a.. c.. g.. .g. .g. ..c . . . gg. .c. ..g a.. g.. a.. . . . . . . . . . . . . . . . - t.. . . .
h5 0 + 1 .g. . . . .c. a.. c.. g.. .g. .g. . . . . . . gg. .c. . . . . . . g.. a.. . . . . . . . . . . . . . . . - . . . . . .
h6 0 + 1 .g. . . . .c. a.. c.. g.. .g. .g. ..c . . . gg. .c. . . . . . . g.. a.. . . . . . . . . . . . . . . . - . . . . . .
h7 1 + 0 .g. . . . .c. a.. c.. g.. .g. .g. ..c . . . . . . .c. ..g a.. g.. a.. . . . . . . . . . . . . . . . - . . . .g.
h8 1 + 0 .g. .g. .c. a.. c.. g.. .g. .g. ..c .a. gg. .c. ..g a.. g.. . . . . . . . . . . . . . . . . . . - . . . . . .
h9 1 + 0 .g. . . . . . . . . . . . . g.. .g. .g. ..c . . . gg. . . . . . . . . . . . . a.. ..t ..c .t. a.. g.t gaa . . . . . .
Amino acid change:
Gly Ser Thr Lys His Glu Gly Ser * Asn Gly Ala Glu Asn Glu Ile * Asp Val Thr Gly Glu Tyr Arg
All seven sequences obtained in this study had codons ctc ttc tcc ttc at the amino end, similar to the Sal I sequence (X_001615090.1); the codons are numbered to this sequence. * No amino acid variation.
N, number of isolates (sequences from PlasmoDB + from this study). (-) Absence of codon. Codons from 69 to 220 and from 258 to 363 correspond to exon-1 and exon-2, respectively. Note that most frequent
haplotypes were present in our study and found in the PlasmoDB repository [19].
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The ML tree using the pvcyrpa coding gene demarcated two main clusters (A and B)
in parasites from Southern Mexico, separated from each other by 88% and 78% bootstrap
values, respectively; both were separated from isolate M760A and the reference sequences
of the Sal I, Belem and P01 strains. Furthermore, haplotypes h1 and h2 from Southern
Mexico in cluster B were separated by bootstrap value >90% (Figure 1). The global ML tree
showed a lack of clustering by region or country. Haplotypes from the same or different
regions were randomly scattered across the tree, and bootstrapping values above 50% were
not observed in the primary or secondary external branches (Figure S2).
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Figure 1. ML phylogenetic tree of the P. vivax cyrpa coding gene for 22 Southern Mexican parasites.
Bootstraps above 50% are indicated. Sal I (XM_001615090.1), Belem, and PvP01 (PlasmoDB) were
included as reference strains. These M760A isolate sequences did not cluster with other Southern
Mexican parasites. The haplotype numbers h1–h9 assigned to each parasite isolate (as in Table 1) are
indicated. * indicate sequences obtained in this study. (Year of sample collection).
3.2. Sequence Diversity of the Pvcyrpa Coding Gene
In P. vivax from Southern Mexico, the slide window analysis showed that nucleotide
(π) and genetic (θ) diversity were heterogeneously distributed across the coding region, and
values were higher in exon-1 than in exon-2 (Figure 2). The pattern of diversity detected in
Southern Mexico was similar to that of paras t s from South America and Asia (Figure 2).
Using the whole coding gene confirmed that Southern Mexico parasites were less
diverse than parasites from other geographic origins (Table 3). For southern Mexican
parasites, the nucl otide (t = 29.619, df = 65, P < 0.0001 unpaired t test) and haplotype
(t = 16.80, df = 65, P < 0.0001) diversity wer low r than those detected in South America,
and, in turn, those in South America had lower nucleotide (t = 10.863, df = 62, P < 0.0001)
and haplotype (t = 0 5.451, df = 62, P < 0.0001) diversity than parasites from Asia (Table 3).
Similar differences were detected when nalyzing each exon separately. The exon-1 se-
quence showed higher nucleotide diversity than that of exon-2, evidenced by the π and θ
values, which were similar for all the parasite groups (Table 3). The nucleotide diversity of
South Am rica and Asian parasites was higher in exon-1 than exon-2 (t = 52.07, df = 88 and
t = 19.443, df = 36 respectively; P < 0.0001).
In contrast, for Southern Mexican parasites the haplotype diversity was higher in the
exon-2 sequence than that of exon-1 (t = 10.08, df = 42, P < 0.0001; 95% CI). For South
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American parasites, the Hd for the exon-1 sequence was slightly higher than that in exon-2
(t = 2.067, df = 88, P = 0.0416), while the Asia group showed no difference in the Hd values
between exons (t = 1.521, df = 36, P = 0.1370).
Figure 2. Slide window analysis of the diversity and Tajima’s D for the P. vivax cyrpa coding gene. Indexes of nucleotide (π)
and genetic diversity (θ); Tajima’s D values varied across the sequence. Graphs show isolates from different geographical
origin. Window length of 100 bp and step size of 25 nucleotides. Significance * P < 0.05; § P < 0.01.
Table 3. Diversity parameters of the P. vivax cyrpa coding gene in Southern Mexican parasites, and in isolates from other
geographic regions.
Diversity Entire Coding Gene: 1083 bp exon-1 (605 bp) exon-2 (478 bp)
Southern Mexico (n = 22)
SS 25 16 9
M 25 16 9
H 9 7 6
Hd ± SD 0.861 ± 0.044 0.697 ± 0.0068 0.797 ± 0.046
π ± DE 0.0086 ± 0.0005 0.0124 ± 0.00086 0.004 ± 0.00084
θw ± (DE nr, fr) 0.0063± (0.0024, 0.0012) 0.00727 (0.00294, 0.00182) 0.00517 (0.0023, 0.00172)
Rm 4 3 0
South America (n = 45)
SS 39 25 14
M 41 27 14
H 27 20 14
Hd ± SD 0.975 ± 0.009 0.92 ± 0.027 0.910 ± 0.018
π ± DE 0.01228 ± 0.00041 0.01467 ± 0.00055 0.00925 ± 0.00043
θw ± (DE nr, fr) 0.00824 (0.00263, 0.00132) 0.00945 (0.00321, 0.00189) 0.00670 (0.00254, 0.00179)
Rm 11 8 2
Asia (n = 19)
SS 40 25 15
M 43 28 15
H 18 16 15
Hd ± SD 0.994 ± 0.019 0.982 ± 0.022 0.971 ± 0.027
π ± DE 0.0138 ± 0.00070 0.01627 ± 0.0010 0.01067 ± 0.00076
θw ± (DE nr, fr) 0.01057 (0.00392, 0.00167) 0.0118 (0.000021; 0.0023) 0.00898 (0.00375, 0.00232)
Rm 12 8 3
SS, segregating sites; M, mutations; H, haplotype; Hd, haplotype diversity; Rm, minimal number of recombination events. InDels were not
included in the analysis.
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3.3. Neutrality Tests
The sliding window analysis of Tajima’s D (TjD) showed significant positive values in
fragments of 100 bp positioned between the 200–500 nucleotides of exon-1 and a negative
value at the 700 nucleotide midpoints (exon-2) in parasites from Southern Mexico (Figure 2).
Parasite isolates from SA and Asia produced a different TjD-value pattern. Parasites from
South America had significant positive values at exon-1, similar to the Southern Mexico
parasites, and additional significant values between fragments comprising the 700–850
nucleotides of exon-2 (Figure 2). Conversely, in Asian parasites, the TjD values were
positive along exon-1 but none were significant. At exon-2, positive significant values were
obtained, similar to those in South America parasites (Figure 2).
The exon-1 analysis showed consistently positive TjD or Fu and Li’D* and/or Fu*and
Li’F* values (Table 4). For isolates from Southern Mexico, the TjD and TjD (nonsynonymous)
were significantly positive; for South American parasites, both the Fu and Li’D* and the
Fu and Li’F* tests were significantly positive; and for the Asian parasites, only the Fu and
Li’D* test was significant (Table 4). In Southern Mexico, the TjD, Fu and Li’D* and Fu and
Li’F* tests showed negative values for exon-2 but were not significant, while for South
America and Asia, the values were around 1.0 and near zero, respectively.
Table 4. Neutrality tests for the P. vivax cyrpa coding sequence; entire sequence and by exon.
Parameters Southern Mexico South America Asia
Coding Gene exon-1 exon-2 Coding Gene exon-1 exon-2 Coding Gene exon-1 exon-2
Syn 3 1 2 5 1 4 5 1 4
Nonsyn 22 15 7 32 22 10 31 20 3 11
Tajima’s D
(TjD) 1.358 2.493
1 −0.713 1.573 1.657 1.178 0.917 0.993 0.704
TjD (syn) 0.638 1.553 −0.174 0.674 0.242 0.688 0.246 −0.035 0.305
TjD (nonsyn) 1.401 2.425 1 −0.805 1.652 1.697 1.210 1.003 1.040 0.787
Fu & Li’D* 0.042 0.870 −1.284 1.3043 2 1.496 1 0.599 0.912 1.443 1 −0.157
Fu & Li’F* 0.513 1.5765 2 −1.297 1.6120 2 1.763 1 0.935 1.045 1.492 2 0.106
syn, synonymous mutations; nonsyn, nonsynonymous mutations. cyrpa, 1083 bp; exon-1, 605 bp; exon-2, 478 bp. P < 0.05 1; 0.10 > P >
0.05 2. Twenty-one changes 3.
The Pvcyrpa coding gene had an excess of nonsynonymous mutations. The analysis of
selection using the differences between rates of nonsynonymous and synonymous changes
(β-α) showed that codons with positive values were more frequent in exon-1 than in exon-2
(Figure 3). Parasites from Southern Mexico showed two codons with positive significant
values. For South American and Asian parasites several codons had positive β-α values
(P < 0.05). The Z test of selection shows that the exon-1 sequence had significant positive
values in parasites of different origin. These values were higher in parasites from South
America or Asia. Meanwhile, the exon-2 sequence showed no deviation from neutrality
(Table 5). The MK neutrality index correlated with the previous results, and only exon-1
sequences had significant positive values (Table 5).
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Table 5. Selection tests for the P. vivax cyrpa coding gene among different parasite groups.
Geographic Origin Gene Fragment Polymorphic Changes withinP. vivax Groups
Z-Test
(dN > dS) P-Value Fixed Differences between Species *
McDonald and Kreitman
(Neutrality Index) P-Value
Synonymous Nonsynonymous Synonymous Nonsynonymous
Southern Mexico:
Coding region 2 21 2.399 0.009 82 84 10.25 <0.001
n = 22 exon-1 1 15 2.101 0.0189 48 56 12.857 0.0020
exon-2 1 6 0.875 0.1912 33 27 7.333 0.0544
South America:
Coding region 4 32 2.8205 0.0028 81 82 7.902 <0.001
n = 45 exon-1 1 23 3.479 <0.001 48 56 19.714 <0.001
exon-2 3 9 0.3909 0.3483 32 25 3.840 0.06238
Asia:
Coding region 4 30 2.883 0.0023 81 84 7.232 <0.001
n = 19 exon-1 1 20 3.529 <0.001 48 56 17.143 <0.001
exon-2 3 10 0.803 0.2116 32 27 3.951 0.0647
Fisher’s exact test * P-value (two tailed). * XM_004221254.1 Plasmodium cynomolgi strain B hypothetical protein (PCYB_053730) mRNA; gaps were not included in the analysis, adjustment to 1071 bp exons 1–2.
Exon-2 showed that mutations had no deviation from neutrality. The Z test was run in MEGA v6 and the MK neutrality index in DnaSP v6. Under neutrality, the ratio of replacement to synonymous fixed
substitutions (differences) between species should be the same as the ratio of replacement to synonymous polymorphisms within species.
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3.4. Linkage Disequilibrium (LD) and Recombination
Using only informative segregating sites, of the 190, 561, and 465 pairwise comparisons
for parasites from Southern Mexico, South America, and Asia, the numbers of significant
comparisons with the Bonferroni correction were 32 (16.8%), 47 (8.3%), and eight (1.7%),
respectively. For parasites from Southern Mexico, the D’ index showed most values
polarized and few within the +0.5/–0.5 range, while R2 values were high, at an average of
0.50 (the ZnS value). The ZnS values were lower for parasites from South America (0.1447)
and Asia (0.099). For Southern Mexico, the regression curve crossed the R2 axis at ≈ 0.8
and decreased steadily, while the regression line of the South American and Asian parasites
crossed the Y axis above and below 0.2, respectively, and decayed slowly (Figure 4). The
minimal recombination events for the entire gene sequence in these parasite groups was 3,
9 and 12 for Southern Mexico, South America and Asia, respectively.
Figure 4. Linkage disequilibrium analysis of the P. vivax cyrpa gene. Parasites from Southern Mexico and other regions. The
D’ and R2 indexes were calculated using only informative sites. For parasites from Southern Mexico, the regression line
emerges at an R2 value of ~0.8 and decreases steadily whereas for the other parasites, the line initiates at ~0.2 and decays
slowly. Most significant values were for nucleotide distances < 300 bp. Exon-1, 1–605nt; intron, 606–828; and exon-2 of 478nt,
823–1306. No gaps were included.
3.5. Prediction of Polymorphic Residues Potentially Participating in the B-Cell Epitope
Figure 5 shows the CyRPA amino acid variation among sequences from the Southern
Mexican parasites. Important amino acid polymorphism was detected in regions predicted
to contain residues participating in B-cell epitopes, and accessible to the protein surface
using BepiPred-2.0. These peptide regions coincided with the amino acid residues detected
as participating in the CyRPA B-cell epitope of P. falciparum [8,34]. The amino acid position
was considered without the signal peptide, as suggested by Chen et al., [35]. At 42 amino
acid, haplotypes h1 and h2 had Ala while the other haplotypes had Gly. Haplotypes h1,
h2 and h9 differed from the other haplotypes at 64 and 67 amino acids—a polar-charged
positive Lys vs. a polar not-charged Thr, and a negatively-charged Glu vs. a positively-
charged Lys, respectively. At the 100, 101, and 103 residues, both h1 and h2 expressed
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Lys-Glu-Ile while the other haplotypes had a different Glu-Gly-Ser sequence. At the
119, 128, 144, 159 residues, the variations were Asn vs. Gly, Asp vs. Ala, Asp vs. Asn,
and Lys vs. Glu, respectively. The h9 haplotype showed unique significant changes—
Glu233Asp, Glu234Val, Pro235Thr, and Ser238Gly—compared to other sequences, and had
the codon insert at 241Glu, present in haplotype h1 (Figure 5). The PvCyRPA sequences
from the South American and Asian parasites showed similar amino acid substitutions in
the predicted B-cell epitopes (Table S2).
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4. Discussion
The cysteine-rich protective antigen (CyRPA) of P. vivax seems to be essential for the
parasite’s life cycle and an alternative ligand for reticulocyte invasion [10]. Significant pro-
tein polymorphism and a high positive selection pressure acting on this protein could limit
its use as a vaccine component or as a serological marker. P. vivax cyrpa from Southern Mex-
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ico and from other locations showed that mutations and recombination have contributed
to generating nucleotide and haplotype diversity. The similarity in the nucleotide diversity
pattern across the coding gene suggests that similar evolutionary forces act on P. vivax cyrpa
parasites of different origin. The phylogenetic trees suggest a weak population structure of
P. vivax using pvcyrpa. The coding gene shows nonsynonymous mutation accumulation,
mainly in exon-1. Pvcyrpa exon-1 had positive and significant values for the TjD and/or D*
and F* (Table 4), selection values (β-α) (Figure 3), Z (HA = dN > dS), and MK tests (Table 5),
which suggest that this exon might be under positive balancing selection pressure. Peptide
regions that have a significant amino acid variation in exon-1, at a broader level than that
in exon-2, are predicted to participate in B-cell epitopes. The coded protein segment from
exon-1 seem to be more exposed to the surface than that from exon-2. The latter seems to
be under structural constraints.
Unlike P. falciparum, both P. knowlesi and P. vivax lack the RH5 gene. Pkcyrpa, as a sin-
gle protein, showed itself to be essential for parasite survival, and probably uses a non-BSG
requisite for erythrocyte invasion [10]. In P. vivax, as in P. knowlesi, PvCyRPA is transcribed
during schizogony. However, its role in P. vivax development has not been determined.
Knuepfer et al. [10] showed that the development of P. vivax blood stages in vitro was sig-
nificantly reduced by anti-Basigin antibodies in some parasite isolates. Targeting molecules
important for the parasite’s life cycle might be limited by their antigenic polymorphism
or low immunogenicity. In P. falciparum, CyRPA showed limited polymorphism and poor
antibody responses in individuals after parasite exposure [3] even though the recombinant
PfCyRPA showed itself to be highly immunogenic [4].
The lower diversity found in P. vivax cyrpa from Southern Mexico, compared to areas
with higher transmission intensity, resembles other genetic markers [34,36,37] and genomic
studies [19]. In this study, the nucleotide diversity at pvcyrpa was higher
(π = 0.0086 ± 0.0005), especially in exon-1 (π = 0.0124 ± 0.00086), than in other microneme
protein segments involved in reticulocyte invasion, e.g., pvdbpII (π = 0.003) and pvama1I-II
(π = 0.007) [34]. PvDBP and PvAMA1 proteins participate in merozoite invasion via the
Duffy antigen receptor for chemokines (DARC) [38]. Those microneme proteins showed
lower nucleotide diversity than the pvmsp142 surface protein [34,39], which is important
when merozoites first come into contact with reticulocytes. The level of polymorphism in
blood-stage antigens seems to be associated with the degree of exposure to the immune
system [33]. In PNG, it was reported that PvCyRPA induced IgG-specific antibodies in chil-
dren, and low levels were associated with protection from clinical disease; thus, antibody
levels against this protein might be considered as a marker of concurrent and past exposure
to P. vivax [11]. Merozoite proteins, such as PvCyRPA, that induce antibody responses, can
be good markers of recent exposure and/or protective immunity [35]; nonetheless, this
awaits further investigation.
In our study, exon-1 showed an excess of nonsynonymous mutations in parasites
of different origin. The positive and significant values of the TjD and other selection
tests (β-α values, Z (HA = dN > dS) and MK tests) suggest that pvcyrpa exon-1 might
be under positive balancing selection pressure in Southern Mexico and other geographic
sites [40]. However, the high and significant TjD values by themselves might reflect parasite
population contraction. In Southern Mexico, a gradual reduction in malaria cases occurred
over the sample collection period (2000–2009, and one sequence from 2015), along with a
loss of haplotypes, probably due to genetic drift. Which caused reduction in the nucleotide
diversity and this is consistent with the high LD and the few Rm detected, when compared
to parasites from South America and Asia. The two most frequent pvcyrpa haplotypes
(h1/h2) in Southern Mexico were genetically closely related with no further diversification
detected, while one divergent haplotype was present in isolate M760A. Furthermore,
P. vivax hypnozoites can be a confounding factor, and some persistent haplotypes might
have corresponded to relapsing parasites [41].
On the other hand, demographic changes in Plasmodium populations might affect
genome-wide sequences, while natural selection acts on specific segments of the genome,
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e.g., drug-resistant genes and antigenic molecules, among others [42,43]. Pvcyrpa shares
characteristics with other merozoite genes that participate in reticulocyte invasion. The
sequence comprises semiconserved segments adjacent to highly variable hotspots that
accumulate nonsynonymous mutations, likely involved in immune evasion [34]. The
h3–h8 haplotypes made up a group of “balanced” haplotypes that were detected across
time. In previous studies, pvama1I-II (but not pvdbpII or pvmsp142) was reported to be
under balancing selection pressure in parasites from Southern Mexico in 2006–2007 [34].
To test the hypothesis that Tajima’s D increased as malaria cases in Southern Mexico
decreased, the pvama-1I-II sequences from a longitudinal study were analyzed. In the 1990s,
a high transmission and control phase, the TjD was positive (2.072; P < 0.05), and these
values remained positive for the 2000–2007 period (of lower transmission). The TjD values
decreased in sequences from 2008–2011 (Figure S3) [19,34]. Additionally, positive selection
scanning in the P. vivax genome from the China-Myanmar border detected signatures of
positive selection acting on pvcyrpa and other blood-stage antigens [43]. In this study, it is
suggested that the Asian population is under positive selection pressure (as shown in the Z
(HA = dN > dS) and MK tests); however, it is advised that further studies are conducted on
a larger sample size to elucidate if correspond to positive balancing signature. The Asian
group comprised only a few pvcyrpa sequences from Thailand, PNG, and China.
This study represents a first insight into PvCyRPA amino acid polymorphism in
residues that potentially participate in linear or conformational B-cell epitopes (Figure 5;
Table S2). The presence of protective conformational epitopes has been suggested in P. fal-
ciparum PfCyRPA [8,34]. In CyRPA, cysteines are largely conserved among Plasmodium
species (including P. vivax) and contribute to the canonical six-bladed β–propeller fold [8].
Alignment of proteins from different species suggests a similar structure but further studies
might elucidate whether similar peptide regions are exposed to the protein surface, and can
induce blocking and protective antibodies. Protein residues of a protective conformational
B-cell epitope were located in P. falciparum [35] on similar peptide segments participat-
ing in PvCyRPA B-cell epitopes using the BepiPred method. These peptide segments
demonstrate an important amino acid polymorphism in P. vivax, likely caused by immune
selective pressure. Further experimental studies are necessary to identify protective linear
and conformational B-cell epitopes in PvCyRPA and in clinical protection, the impact of
amino acid variation in immune evasion, and/or peptide regions that are valuable as
serological markers.
Interestingly, the pvcyrpa intron distinguished the h1 from the h2 haplotype (defined
by the coding gene), which might indicate differences in the evolutionary history of the
parasites. Introns are not under selective pressure so the limited parasite recombination be-
tween some haplotypes has probably been driven by vector restriction. In Southern Mexico,
the two main P. vivax populations (North American and Central/South American) con-
verged, likely transmitted by different subgenera, namely the Anopheles or Nyssorhynchus
species [33].
5. Conclusions
The degree of nucleotide and haplotype diversity was associated to the low trans-
mission intensity in Southern Mexico. Regardless of the parasite’s geographic origin, the
pattern of nucleotide diversity across the coding region was similar; this indicates that
the structural and/or functional properties are consistent. The results suggest that poly-
morphism at pvcyrpa exon-1 is generated by mutation and recombination, and is probably
maintained by positive balancing selection, which might represent an evolutionary ad-
vantage to the parasite. Amino acid variation was present at peptide regions potentially
participating in B-cell epitopes, which supports the idea that this molecule is under selec-
tive immune pressure. A characteristic of malaria blood stage antigens is their participation
in merozoite invasion and/or immune evasion. Immunogenicity studies and molecular
modeling are required to determine the importance of PvCyRPA as a vaccine candidate
and/or a serological marker.
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